| Name | Title | Contact Details |
|---|
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
First Plan Of Minnesota is a Duluth, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals.
Author of Kitchen Table Wisdom and My Grandfathers Blessings, Clinical Professor, Family and Community Medicine, UCSF. www.rachelremen.com
Eastern Area Adult Services is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.